Trial · NCT00499863
Outcomes12
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change From Baseline in the Attention Deficit Hyperactivity Disorder Rating Scale-fourth Edition (ADHD-RS-IV) Total Score at Endpoint | baseline and endpoint (up to 7 weeks) | Intent-to-treat (ITT) which included all randomized subjects who received at least one dose of MTS or PTS, and had one Baseline and at least one post-Baseline assessment. | scores on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in the Conner's Parent Rating Scale-Revised (CPRS-R) Total Score at Endpoint | Baseline and endpoint (up to 7 weeks) | ITT | scores on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Improvement in Clinical Global Impressions-Improvement (CGI-I) Score | up to 7 weeks | ITT | Participants | NUMBER |
| SECONDARY | Improvement in Parent Global Assessment (PGA) Score | up to 7 weeks | ITT | Participants | NUMBER |
| SECONDARY | Change From Baseline in Youth Quality of Life-research Version (YQOL-R) Total Score at Endpoint | Baseline and endpoint (up to 7 weeks) | ITT | scores on a scale | LEAST_SQUARES_MEAN |
| OTHER_PRE_SPECIFIED | Post Sleep Questionnaire (PSQ) Quality of Sleep | up to 7 weeks | Safety population (Note: not everyone in the safety population completed a sleep questionnaire) | Participants | NUMBER |
| SECONDARY | Dermal Response Scale (DRS) Scores | up to 7 weeks | Safety population which included all randomized subjects that received at least one dose of MTS or PTS. | scores on a scale | MEAN |
| SECONDARY | Change From Baseline in Electrocardiogram Results(QTcF Interval) at Endpoint | Baseline and endpoint (up to 7 weeks) | Safety population | msec | MEAN |
| SECONDARY | Change From Baseline in Pulse Rate at Endpoint | Baseline and endpoint (up to 7 weeks) | Safety population | bpm | MEAN |
| SECONDARY | Change From Baseline in Systolic Blood Pressure at Endpoint | Baseline and endpoint (up to 7 weeks) | Safety population | mmHg | MEAN |
| SECONDARY | Change From Baseline in Diastolic Blood Pressure at Endpoint | Baseline and endpoint (up to 7 weeks) | mmHg | MEAN | |
| SECONDARY | Change From Baseline in Weight at Endpoint | Baseline and endpoint (up to 7 weeks) | Safety population | lbs | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00499863/outcomes